Matches in SemOpenAlex for { <https://semopenalex.org/work/W2791806317> ?p ?o ?g. }
- W2791806317 endingPage "17" @default.
- W2791806317 startingPage "11" @default.
- W2791806317 abstract "Background Fibroblast growth factor 21 is a signalling protein involved in cell differentiation, morphogenesis, proliferation and metabolism. Recent studies have associated increased levels of FGF21 in the development of cardiovascular diseases, whereas others have reported no significant associations. Therefore, this systematic review and meta-analysis evaluated the value in predicting the risk of cardio-metabolic disorders and mortality. Methods PubMed and EMBASE were searched until 5th September 2017 for studies that evaluated the roles of FGF21 levels in cardio-metabolic disorders. Results A total of 183 and 301 entries were retrieved; 24 studies met the inclusion criteria. Four studies were identified by an additional search. Therefore, 28 studies were included in the final meta-analysis. High FGF21 levels significantly predicted the incidence of coronary artery disease (hazard ratio [HR]: 1.29; 95% confidence interval [CI]: 1.06–1.55; P < 0. 01; I2 = 48%) and the risk of metabolic syndrome (HR: 1.70, 95% CI: 1.35–2.15; P < 0.0001 I2 = 24%). In diabetes mellitus, FGF21 predicted disease incidence or progression (HR: 1.35, 95% CI: 1.06–1.72, P < 0.05, I2 = 69%) and worsening renal failure (HR: 1.06, 95% CI: 1.03–1.09, P < 0.0001, I2 = 47%). FGF21 also predicted all-cause mortality (HR: 3.00, 95% CI: 1.23–7.33; P < 0.05; I2 = 51%), and cardiovascular mortality (HR: 2.33, 95% CI: 1.08–4.99, P < 0.05, I2 = 75%). Conclusion FGF21 significantly predicts the incidence of coronary artery disease, the risks of metabolic syndrome, diabetes mellitus and renal progression in diabetes. It also predicted all-cause and cardiovascular mortality." @default.
- W2791806317 created "2018-03-29" @default.
- W2791806317 creator A5010032623 @default.
- W2791806317 creator A5018370771 @default.
- W2791806317 creator A5019246193 @default.
- W2791806317 creator A5033815471 @default.
- W2791806317 creator A5033997612 @default.
- W2791806317 creator A5043075532 @default.
- W2791806317 creator A5046775442 @default.
- W2791806317 creator A5056447268 @default.
- W2791806317 creator A5059788514 @default.
- W2791806317 creator A5062301609 @default.
- W2791806317 creator A5068742346 @default.
- W2791806317 date "2018-06-01" @default.
- W2791806317 modified "2023-10-13" @default.
- W2791806317 title "Fibroblast growth factor 21 in cardio-metabolic disorders: a systematic review and meta-analysis" @default.
- W2791806317 cites W1800862889 @default.
- W2791806317 cites W1802508672 @default.
- W2791806317 cites W1894138328 @default.
- W2791806317 cites W1968091833 @default.
- W2791806317 cites W1978039711 @default.
- W2791806317 cites W1987319584 @default.
- W2791806317 cites W1991653577 @default.
- W2791806317 cites W2005256087 @default.
- W2791806317 cites W2005896531 @default.
- W2791806317 cites W2007215002 @default.
- W2791806317 cites W2025139842 @default.
- W2791806317 cites W2032787352 @default.
- W2791806317 cites W2039844480 @default.
- W2791806317 cites W2051453708 @default.
- W2791806317 cites W2054195724 @default.
- W2791806317 cites W2062842771 @default.
- W2791806317 cites W2080977866 @default.
- W2791806317 cites W2085379045 @default.
- W2791806317 cites W2095244962 @default.
- W2791806317 cites W2095480970 @default.
- W2791806317 cites W2109071746 @default.
- W2791806317 cites W2114320250 @default.
- W2791806317 cites W2114836473 @default.
- W2791806317 cites W2119351413 @default.
- W2791806317 cites W2129100766 @default.
- W2791806317 cites W2129631252 @default.
- W2791806317 cites W2130095877 @default.
- W2791806317 cites W2131622156 @default.
- W2791806317 cites W2136624264 @default.
- W2791806317 cites W2144205195 @default.
- W2791806317 cites W2147029239 @default.
- W2791806317 cites W2156098321 @default.
- W2791806317 cites W2166878182 @default.
- W2791806317 cites W2168649725 @default.
- W2791806317 cites W2171151924 @default.
- W2791806317 cites W2273543170 @default.
- W2791806317 cites W2294754341 @default.
- W2791806317 cites W2346288794 @default.
- W2791806317 cites W2511435501 @default.
- W2791806317 cites W2521812521 @default.
- W2791806317 cites W2522393208 @default.
- W2791806317 cites W2534437442 @default.
- W2791806317 cites W2558467589 @default.
- W2791806317 cites W2559869355 @default.
- W2791806317 cites W2580171632 @default.
- W2791806317 cites W2584665637 @default.
- W2791806317 cites W2621875245 @default.
- W2791806317 cites W2622420309 @default.
- W2791806317 cites W2627046105 @default.
- W2791806317 cites W2738596812 @default.
- W2791806317 cites W2747715486 @default.
- W2791806317 cites W2760492005 @default.
- W2791806317 cites W2991792334 @default.
- W2791806317 doi "https://doi.org/10.1016/j.metabol.2018.01.017" @default.
- W2791806317 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29410351" @default.
- W2791806317 hasPublicationYear "2018" @default.
- W2791806317 type Work @default.
- W2791806317 sameAs 2791806317 @default.
- W2791806317 citedByCount "43" @default.
- W2791806317 countsByYear W27918063172018 @default.
- W2791806317 countsByYear W27918063172019 @default.
- W2791806317 countsByYear W27918063172020 @default.
- W2791806317 countsByYear W27918063172021 @default.
- W2791806317 countsByYear W27918063172022 @default.
- W2791806317 countsByYear W27918063172023 @default.
- W2791806317 crossrefType "journal-article" @default.
- W2791806317 hasAuthorship W2791806317A5010032623 @default.
- W2791806317 hasAuthorship W2791806317A5018370771 @default.
- W2791806317 hasAuthorship W2791806317A5019246193 @default.
- W2791806317 hasAuthorship W2791806317A5033815471 @default.
- W2791806317 hasAuthorship W2791806317A5033997612 @default.
- W2791806317 hasAuthorship W2791806317A5043075532 @default.
- W2791806317 hasAuthorship W2791806317A5046775442 @default.
- W2791806317 hasAuthorship W2791806317A5056447268 @default.
- W2791806317 hasAuthorship W2791806317A5059788514 @default.
- W2791806317 hasAuthorship W2791806317A5062301609 @default.
- W2791806317 hasAuthorship W2791806317A5068742346 @default.
- W2791806317 hasConcept C106646824 @default.
- W2791806317 hasConcept C120665830 @default.
- W2791806317 hasConcept C121332964 @default.
- W2791806317 hasConcept C126322002 @default.
- W2791806317 hasConcept C134018914 @default.